Intracellular glutathione as a determinant of responsiveness to antitumor drugs
- 1 October 1986
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 35 (19), 3323-3326
- https://doi.org/10.1016/0006-2952(86)90430-2
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Augmentation of adriamycin, melphalan, and cisplatin cytotoxicity in drug-resistant and -sensitive human ovarian carcinoma cell lines by buthionine sulfoximine mediated glutathione depletionBiochemical Pharmacology, 1985
- L1210(A) mouse lymphoma cells depleted of glutathione with L-buthionine-S-R-sulfoximine proliferate in tissue cultureBiochemical and Biophysical Research Communications, 1984
- GLUTATHIONEAnnual Review of Biochemistry, 1983
- Enhancement of vincristine- and adriamycin-induced cytotoxicity by verapamil in P388 leukemia and its sublines resistant to vincristine and adriamycinBiochemical Pharmacology, 1982
- Protective role of the glutathione redox cycle against adriamycin-mediated toxicity in isolated hepatocytesBiochemical Pharmacology, 1981
- Mixed-function oxidase enzymes in adriamycin-sensitive and resistant sublines of P-388 leukemiaChemico-Biological Interactions, 1981
- Binding specificity of chemically and enzymatically activated anthracycline anticancer agents to nucleic acidsChemico-Biological Interactions, 1980
- Uptake and retention of adriamycin and daunorubicin by sensitive and anthracycline-resistant sublines of P388 leukemiaBiochemical Pharmacology, 1978
- Active outward transport of daunomycin in resistant ehrlich ascites tumor cellsBiochimica et Biophysica Acta (BBA) - Biomembranes, 1973
- Sites of Inhibition of DNA Synthesis by Kethoxal bis(Thiosemicarbazone)Nature, 1968